Beyond the Scale: Multinational Study Links Popular GLP-1 Weight Loss and Diabetes Drugs to Unexpected Nail, Hair, and Scalp Complications
Executive Overview The meteoric rise of glucagon-like peptide-1 (GLP-1) receptor agonists—such as Ozempic, Wegovy, Mounjaro, Zepbound, Victoza, and Trulicity—has fundamentally reshaped modern medicine. Hailed as revolutionary tools for combating obesity…
